Innate immunity contributes to host defense through all cell types and relies on their shared germline genetic background, whereas adaptive immunity operates through only 3 main cell types, ab T cells, gd T cells, and B cells, and relies on their somatic genetic diversification of antigen-specific responses. Human inborn errors of innate immunity often underlie infectious diseases. The range and nature of infections depend on the mutated gene, the deleteriousness of the mutation, and other ill-defined factors. Most known inborn errors of innate immunity to infection disrupt the development or function of leukocytes other than T and B cells, but a growing number of inborn errors affect cells other than circulating and tissue leukocytes. Here we review inborn errors of innate immunity that have been recently discovered or clarified. We highlight the immunologic implications of these errors. (J Allergy Clin
Innate immunity is a germline-encoded system that enables eukaryotes to defend themselves against infection.
1,2 It consists of 3 main components: (1) anatomic barriers, such as the physical barrier of intact skin and the chemical barrier of low gastric pH; (2) soluble proteins secreted onto mucosal surfaces or into the bloodstream, such as complement factors; and (3) a cellular compartment composed of both hematopoietic and nonhematopoietic cells. Antigen-presenting cells (APCs), such as dendritic cells (DCs); phagocytes, such as neutrophils; cytotoxic/cytolytic cells, such as natural killer (NK) cells; and other innate lymphoid cells (ILCs), together with nonhematopoietic cells, such as fibroblasts, keratinocytes, epithelial cells, and neurons, harbor pathways that allow an adequate response to infection.
Pathogens are first detected through innate immune sensors or receptors. Several classes of microbial receptors have been described: Toll-like receptors (TLRs), retinoic acid-inducible protein 1 (RIG-I)-like receptors (RLRs), Nod-like receptors, C-type lectin receptors (CLRs), and DNA sensors. [3] [4] [5] These receptors recognize microbial structures, such as lipoproteins, LPS, flagellin, peptidoglycan, or microbial nucleic acids. Recognition activates downstream signaling cascades, leading to a rapid (occurring within hours) but short-lived immune response. This early immune response enables the host to survive until an adaptive response is generated, but its excessive activation can trigger autoinflammation, which is defined as damage caused by dysregulated innate immune cells to host tissues. 6, 7 Cell-intrinsic immunity is a branch of innate immunity in which a set of cellular antimicrobial defenses protects individual hematopoietic and nonhematopoietic cells against microbes, especially viruses, through autocrine pathways and intracellular mechanisms, such as production of viral restriction factors. 8, 9 The study of inborn errors of immunity was long dominated by the concept of ''conventional'' primary immunodeficiencies (PIDs), in which rare Mendelian traits confer susceptibility to infection with a multitude of pathogens in a completely penetrant manner and with a measurable effect on immune cell number or function. The prototype of such PIDs is X-linked (XL) agammaglobulinemia, which is caused by deleterious mutations in the Bruton tyrosine kinase gene (BTK). Bruton tyrosine kinase is expressed in hematopoietic cells, and defects of this protein render the host susceptible for life to recurrent life-threatening infections with various microbes and result in a detectable immunologic phenotype (little or absent immunoglobulin production and few or absent B lymphocytes).
In the 1910s, Nicolle described asymptomatic infections and documented the natural variability in host susceptibility to infection. In line with these observations, ''monogenic infections'' were described from the 1940s onward, and their molecular basis was described from the 1970s onward. Increased and selective susceptibility to infections with one or a narrow range of pathogens can be referred to as ''nonconventional'' PIDs and include many inborn errors of innate immunity. 10 An example is the susceptibility to invasive Neisseria species infections in patients with late complement pathway defects. [11] [12] [13] Over the last 2 decades, susceptibility to a narrow range of microbes, such as monogenic susceptibility to invasive pneumococcal disease (IPD), Mendelian susceptibility to mycobacterial disease (MSMD), herpes simplex virus 1 (HSV-1) encephalitis (HSE), and fungal disease, particularly chronic mucocutaneous candidiasis (CMC), have been ascribed to defects in single genes, often but not always encoding components of innate immunity. 13, 14 However, dichotomous classifications making distinctions between adaptive and innate immunity, not to mention cell-intrinsic immunity, represent an oversimplification and prove difficult to apply to inborn errors of immunity. In fact, inborn errors of innate immunity can result in the absence or impaired production of cytokines essential for the development, survival, proliferation, or function of B or T cells and can lead to allergy and autoimmunity, indications of adaptive immune dysregulation.
In this review we explore a set of inborn errors affecting ''primarily'' innate immunity, acknowledging their effect on the adaptive immune response. We focus on recently described gene defects in the cellular compartment of the innate immune response or on new insights into the pathogenesis of previously described defects (Table I) . Therefore, although key to innate immunity against infections, the complement system (comprehensively reviewed elsewhere 63, 64 ) will not be discussed here. For the recently described CD55 deficiency, we refer to the original publication. 65 
DEFECTS IN INNATE IMMUNE DEFENSE AGAINST COMMENSAL PYOGENIC BACTERIA AND FUNGI
Pyogenic bacteria, such as Streptococcus pneumoniae and Staphylococcus aureus, and fungi, such as Candida albicans, are commensals of the human skin or mucosa and rarely cause severe disease. Therefore detailed analysis of the immune system is warranted in patients with invasive or recurrent pyogenic or fungal disease. 66 The canonical nuclear factor k light-chain enhancer of activated B cells (NF-kB) pathway is key in the innate immune response to this group of pathogens (Fig 1, A) . 67 Notably, proximal defects in the pattern recognition receptor signaling pathway underlie susceptibility to a narrow spectrum of pyogenic infections, whereas defects in more distal components of the NFkB pathway result in broader phenotypes, including susceptibility to a range of infectious agents and developmental delay. Aside from NF-kB-related immune responses, important pathways in bacterial and fungal killing are phagocytosis and the filtration of encapsulated bacteria by the spleen.
Defects in the NF-kB pathway
The NF-kB pathway consists of (1) a canonical pathway responsible for antimicrobial defense that relies on NF-kB essential modulator (NEMO)/inhibitor of NF-kB kinase (IkB kinase [IKK]) g-, IKKa-, and IKKb-mediated degradation of IkB a/b/ε for the transfer of heterodimers formed by RelA or cRel and p50 to the nucleus, and (2) a noncanonical pathway that regulates lymphoid organogenesis, bone formation, B-cell survival and function and critically depends on NF-kB-inducing kinase (NIK) and IKKa-mediated processing of p100 into p52 to allow formation of nuclear RelB:p52 dimers (Fig 1) . NF-kB operates downstream from TLRs/IL-1 receptor (IL-1R) through a TLRdependent adaptor, myeloid differentiation factor (MyD88), and the IL-1 receptor-associated kinase (IRAK) complex, a dimer of the 2 active kinases IRAK-1 and IRAK-4. The canonical NFkB pathway is also activated downstream from B-cell receptors and T-cell receptors (TCRs), NK cell receptors (eg, NKG2D), TNF receptor superfamily, and CLRs (Dectin-1, Dectin-2, and Mincle), and its effects are mediated by the CARD-BCL10-MALT1 (CBM) complex, consisting of caspase recruitment domain (CARD) molecules, such as CARD9 and CARD11, Bcell lymphoma/leukemia 10 (BCL10), and mucosa-associatedlymphoid tissue lymphoma-translocation gene 1 (MALT1). Additionally, linear ubiquitination, catalyzed by the linear ubiquitination chain assembly complex (LUBAC; formed by hemeoxidized IRP2 ubiquitin ligase 1 [HOIL-1], HOIL-1-interacting protein [HOIP] , and shank-associated RH domain-interacting protein) plays a crucial role in NF-kB activation.
Upstream defects of the TLR and/or IL-1R signaling pathway. Biallelic loss-of-function mutations in IRAK4 and MyD88 were identified in 2003 and 2008, respectively, in children with pyogenic bacterial infections (IPD and staphylococcal and Pseudomonas aeruginosa infections) and little clinical and biological inflammation. 68, 69 Of note, the incidence of IPD typically decreases from adolescence onward, and the mortality of these 2 inborn errors of immunity decreases with age. 70, 71 IRAK1. The role of IRAK-1 in the TLR/IL-1R signaling pathway was partially unveiled with the description of a boy who did not have invasive pyogenic infections but did have weak inflammatory responses, such as seen in MyD88-and IRAK-4-deficient patients. He carried a de novo Xq28 microdeletion spanning Methyl CpG-binding protein 2 (MECP2) and IRAK1.
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IRAK-1 is expressed in lymphocytes, granulocytes, and monocytes, and therefore any deficiency in this protein would be likely to affect both innate and adaptive immunity. In vitro studies of the patient's cells showed IRAK-1 to be largely redundant for TLR/ IL-1R signaling in PBMCs and for the IL-1R response in fibroblasts but essential for signaling downstream from TLR2/6, TRL4, TLR7, and TLR8 in the patient's fibroblasts and EBVimmortalized B (EBV-B) cells. However, because the patient died at 7 months of age of MECP2 deficiency-related encephalopathy, it was not possible to determine the complete clinical and cellular phenotypes of IRAK-1 deficiency. Therefore the identification and study of additional patients with IRAK-1 deficiency are required.
TIRAP. In a child presenting with S aureus pneumonia and sepsis, a rare homozygous variant of Toll/IL-1 receptor domain-containing adaptor (TIRAP) necessary for recruitment of MyD88 to TLR2 and TLR4 was found. 16 The authors showed that the mutation was a loss-of-function (LOF) mutation and resulted in severely impaired responses to TLR1/2 and TLR4 stimulation and completely abolished responses to TLR2/6 in various cell types (Simian-virus 40 fibroblasts, granulocytes, and monocytes) in vitro. 16 Intriguingly, 7 healthy relatives were homozygous for the same variant but had never had severe bacterial infections. Anti-staphylococcal lipoteichoic acid (LTA) antibodies have been shown to enhance response to LTA (a ligand of TLR2) and could not be detected in the patient's plasma yet were present in the healthy relatives. TLR2 activation in response to LTA was rescued in vitro through addition of anti-LTA antibody-containing control plasma or anti-LTA mAb to the patient's whole blood or PBMCs. Hence human autosomalrecessive (AR) TIRAP deficiency results in invasive staphylococcal disease only in the absence of anti-LTA antibodies. 16 This demonstrates the redundancy of TIRAP in the presence of anti-LTA antibodies, underlying the interrelatedness of the innate and adaptive immune response: human adaptive immunity can in fact rescue an inborn error of innate immunity.
Inborn errors of NF-kB signaling. Defects in NF-kB activation lead to a broad range of developmental manifestations and infections caused by impaired signaling pathways downstream of both innate and adaptive immune system receptors, as has recently been reviewed comprehensively by Zhang et al. 72 Autosomal-dominant (AD) mutations in NFKB1, encoding p105/p50, and in NFKB2, encoding p100/p52, result in a common variable immunodeficiency phenotype with recurrent infections and autoimmunity. [73] [74] [75] [76] [77] [78] Null mutations in IKBKG, encoding IKKg, which is also known as NEMO, were described in 2000 to cause incontinentia pigmenti in female subjects and early fetal loss in male subjects, whereas hypomorphic mutations classically cause XL recessive anhidrotic ectodermal dysplasia with immunodeficiency. 79 , 80 The first AD form of EDA-ID was identified [59] [60] [61] [62] AML, Acute myeloid leukemia; CBM, CARD-BCL10-MALT1 complex; CNS, central nervous system; CP, complete penetrance; GI, gastrointestinal; HPV, Human papillomavirus; HVS-T, Herpesvirus saimiri2immortalized T cell; IBD, inflammatory bowel disease; IL6ST, IL-6 signal transducer; IP, incomplete penetrance; MMR, measles-mumps-rubella; NA, not applicable; OMIM, Online Mendelian Inheritance in Man; OSM, oncostatin M; pDC, plasmacytoid DC; PDR, reticulate pigmentary disorder; PEC, pulmonary epithelial cells; POLA1, DNA polymerase a 1; SGD, specific granule deficiency; SV-40 fibroblast, simian virus 402immortalized fibroblast.
in 2003 in a patient with a phenotype similar to XL-EDA-ID. It was caused by gain-of-function (GOF)/hypermorphic mutations in NFKBIA, encoding IkBa. In patients with these disorders, hematopoietic stem cell transplantation (HSCT) can only cure the hematopoietic defect but not the cell-intrinsic immunity of nonhematopoietic cells. 81, 82 Biallelic mutations in IKBKB, encoding IKKb, were identified as the cause of disrupted NF-kB signaling in patients with clinical characteristics of severe combined immunodeficiency (SCID), including early-onset severe viral, bacterial, and fungal infections, despite normal B-and T-cell counts. The patients displayed impaired T-and B-cell activation and proliferation, particularly with a defect of TCRgd T cells, hypogammaglobulinemia, and NK cell deficiency. 83, 84 Finally, homozygous LOF mutations in mitogen-activated protein kinase 14 (MAP3K14), encoding NIK, are responsible for disruption of noncanonical NF-kB activation and an SCID phenotype with numeric and functional defects of B, T, and NK cells. 85 Inborn errors of the CBM complex. CARD11, MALT1, and BCL10 deficiency all result in a similar phenotype of recurrent pyogenic and severe viral infections, yet an intestinal inflammatory phenotype predominates in patients with MALT1 deficiency, [86] [87] [88] [89] and patients with CARD11 deficiency are typically highly susceptible to Pneumocystis species infection. 90, 91 Immunologically, patients present with combined immunodeficiency with normal total numbers of Tand B cells, mostly displaying a naive phenotype, and impaired TCR and B-cell receptor responses. 86, [90] [91] [92] [93] [94] The underlying reason for these specific cellular phenotypes remains unclear because BCL10 has been shown to be strongly expressed in bronchial and intestinal epithelial cells and, to a lesser extent, in lymphocytes and myeloid cells. 93 MALT1 is expressed primarily in lymphocytes and myeloid cells, and CARD11 is expressed primarily in lymphocytes. Moreover, P erez de Diego et al 93 reported a strong impairment of NF-kB-mediated fibroblast function but normal monocyte-derived macrophage and DC responses to stimulation of TLR4, TLR2/6, and Dectin-1 in patients with BCL10 deficiency.
CARD9. First described by Glocker et al 17 in 2009, biallelic mutations in CARD9 are deleterious for innate immune defense against invasive fungal infections. Affected patients are particularly susceptible to superficial (CMC) or invasive (central nervous system) Candida species infections, superficial or deep dermatophytosis, subcutaneous or invasive phaeohyphomycosis (caused by dematiaceous fungi), invasive Exophiala species infections, and extrapulmonary aspergillosis. 17, [95] [96] [97] [98] Proinflammatory cytokine or chemokine responses to various fungal agonists were found to be impaired in patients' whole blood, monocytederived DCs, and macrophages. 95, 97, 99, 100 Additionally, a defect in fungal killing by neutrophils and defective T H 17 immunity were reported in some patients. 99 ,100 A recent study of 2 patients with invasive extrapulmonary aspergillosis and null CARD9 mutations showed that CARD9-deficient neutrophils killed Aspergillus species effectively but did not accumulate at sites of infection, an observation also made in patients with Candida species infection of the central nervous system. 98, 100 However, the precise mechanism of susceptibility to invasive fungal infection in patients with CARD9 deficiency remains to be defined.
Inborn errors of LUBAC. HOIL-1 and HOIP. Three patients from 2 kindreds presenting with invasive pyogenic infections associated with autoinflammation and amylopectinosis-related myopathy and cardiomyopathy were found to have autosomal-recessive (AR) HOIL-1 deficiency caused by homozygous LOF mutations in HOIL1. 18 A patient with similar manifestations, together with viral infections, lymphangiectasia, lymphopenia, antibody deficiency, and impaired T-cell function, harbored biallelic LOF mutations in HOIP. 18, 19 Deficiencies of HOIL-1 or HOIP result in destabilization of LU-BAC, impaired linear ubiquitination of NEMO, and ultimately weak NF-kB activation. 18, 19, 101, 102 Linear ubiquitination by LU-BAC has been shown recently to restrict the growth of bacteria invading the cytosol by activating autophagy and NF-kB. 103, 104 HOIP-and HOIL-1-deficient fibroblasts display impaired NFkB activation in response to TNF and IL-1b. 18, 19 By contrast, whole blood and monocytes from both HOIP-and HOIL-1-deficient patients responded strongly to IL-1b in terms of IL-6 production, which was significantly greater than control values. The excessive monocyte response observed in these patients might account for their clinical autoinflammation. 18, 19 Phagocyte defects Phagocyte defects comprise disorders in phagocyte numbers or function (adhesion, chemotaxis, and/or killing) and were recently reviewed. [105] [106] [107] Defects in the number of phagocytes, such as congenital neutropenia, present in infancy with severe and invasive pyogenic and fungal infections, as well as mucosal inflammation, and are associated with an increased risk of myelodysplastic syndrome (MDS) or leukemia. Mutations in elastase neutrophilexpressed (ELANE) are responsible for around 50% of congenital neutropenia cases. 107 A second set of defects results in impaired phagocyte adhesion, chemotaxis and/or motility, manifesting as delayed healing of the umbilical cord and omphalitis, bacterial/ fungal infections, poor wound healing, periodontitis and syndromic features. 108 Finally, mutations in genes encoding proteins responsible for superoxide production (gp91phox, p22phox, p47phox, p67phox, and p40phox) and thus for bacterial and fungal killing cause chronic granulomatous disease, manifesting with severe infections, especially in the form of abscesses, granulomata, and an autoinflammatory phenotype. 109, 110 Here we discuss a number of newly described genes responsible for neutrophil defects.
Severe congenital neutropenia. VPS45. Vilboux et al 20 and Stepensky et al 21 independently investigated 13 children with severe congenital neutropenia (SCN) who did not carry mutations in ELANE and who were resistant to granulocyte colonystimulating factor (G-CSF) treatment. The patients all presented before 6 months of age with severe to fatal pyogenic and fungal infections (mainly with Pseudomonas species, S aureus and other gram-positive bacteria, and Aspergillus species), manifesting as omphalitis, superficial and deep abscesses, pneumonia, osteomyelitis, and sepsis. Neurological involvement and myelofibrosis with extramedullary hematopoiesis causing hepatosplenomegaly, nephromegaly, or both were also striking. Five of them succumbed to infection, and 6 received HSCT, 4 of whom survived. 20, 21, [111] [112] [113] These patients were found to carry homozygous mutations in vacuolar sorting-associated protein 45 (VPS45). 20, 21 VPS45 is a regulator primarily associated with Golgi, transport vesicles, and endosomal membranes. It is required for intracellular trafficking and recycling of proteins through the endocytic-lysosomal pathway. The described mutations lead to accelerated neutrophil and bone marrow myeloid cell apoptosis, as well as thrombocytopenia and thrombasthenia caused by impaired granule metabolism. 20, 21 Other lysosome-related proteins are responsible for neutropenia (eg, in patients with Chediak-Higashi syndrome, Hermansky-Pudlak syndrome type 2, and Griscelli syndrome type 2), but the exact mechanism underlying the neutropenia in defects of endosomal-lysosomal proteins is unknown. JAGN1. Another cause of SCN unresponsive to G-CSF was reported by Boztug et al, 22 who identified homozygous mutations in the Jagunal homolog 1 (JAGN1) gene in 14 patients with SCN. They manifested pyogenic bacterial infections, myeloid maturation arrest, and bone and teeth abnormalities. Sixteen patients have been reported thus far; 1 succumbed to sepsis, and 2 were successfully treated with HSCT. 22, 114 JAGN1 is an endoplasmic reticulum (ER) protein involved in vesicular trafficking between the ER and the Golgi. It plays a crucial role in neutrophil differentiation and survival. 22 JAGN1 deficiency affects primarily neutrophils, which display scarce specific granules, as well as aberrant ER structure and function, resulting in anomalous N-glycomic profiles and increased apoptosis. 22 Furthermore, the defect in N-glycosylation also affects the G-CSF receptor, possibly explaining common G-CSF resistance in these patients.
CSF3R. Biallelic defects of the G-CSF receptor-encoding gene CSF3R are responsible for another AR form of SCN characterized by peripheral neutropenia without granulocyte maturation arrest and complete resistance to G-CSF treatment. 23, 115 Expression of the mutant receptor on the cell membrane is severely reduced or completely abolished, 23, 115 leading to absence of G-CSF response and neutropenia. Of note, mutations of CSF3R have been associated with acute myeloid leukemia in patients with SCN. These acquired somatic mutations affect the transmembrane or intracellular domain of the receptor, whereas mutations underlying neutropenia are germline and affect the extracellular domain of the protein, as reviewed by Klimiankou et al.
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SMARCD2. Witzel et al 24 recently reported 4 patients with delayed separation of umbilical cord, intractable diarrhea with failure to thrive, pneumonia, abscesses and recurrent sepsis, dysmorphic features, and skeletal anomalies. Bone marrow analysis demonstrated scarcity of neutrophils with a granulocyte maturation arrest, neutrophil-specific granule deficiency, and progression to MDS with blast excess in all patients; furthermore, 1 patient had myelofibrosis. Two patients have undergone successful HSCT at 1 and 2 years of age, respectively, and 2 succumbed to septic shock at 1 month and at 5 years of age. 24 In these patients homozygous mutations in SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily D, member 2 (SMARCD2) were identified. SMARCD2 is part of a SWI/SNF (switch/sucrose nonfermentable) complex, a family of chromatin-remodeling factors responsible for unwrapping of nucleosomes and necessary for regulation of differentiation in hematopoietic stem cells. Priam et al 117 have confirmed the essential role of SMARCD2 in granulopoiesis and granule production in neutrophils.
Defects in chemotaxis. WDR1. In the 1970s, a defect in neutrophil actin polymerization and chemotaxis was described (the so-called lazy leukocyte syndrome), but no genetic cause could be determined. 118, 119 Affected patients had mild neutropenia, abnormal neutrophil migration/mobilization, and abnormal neutrophil morphology with nuclear lobe herniation and absence of cytosolic granules. In 2016, Kuhns et al 25 described 5 additional patients with lazy leukocyte syndrome who had recurrent sinopulmonary and life-threatening systemic pyogenic infections, as well as severe chronic stomatitis, leading to oral stenosis. One patient succumbed to overwhelming infection and HSCT was life-saving in another patient. The group identified biallelic mutations in WD repeat domain 1 (WDR1), the gene encoding actin-interacting protein 1 (Aip1), as a cause of this syndrome. 25 Aip1 is required for adequate actin rearrangement, and Aip1-deficient neutrophils display defects in polarization, chemotaxis, and survival.
Another homozygous mutation of WDR1 was recently reported as the cause of severe autoinflammatory disease, periodic fever, severe stomatitis with oral stenosis, and immunodeficiency with severe recurrent infections in 2 girls from a consanguineous family. 120 They displayed increased inflammasome activation with high serum IL-18 levels and poor T-cell proliferation in vitro but no neutropenia. One patient succumbed to the disease, and the other has been successfully treated with HSCT. 120 These findings underline once again the key role of the actin cytoskeleton in human immune responses. 121 
Defect in a lymphoid organ: Isolated congenital asplenia
The spleen is a secondary lymphoid organ organized in white and red pulp separated by a marginal zone, serving critical functions both in innate and in adaptive immunity. 122 Especially the marginal zone macrophages constitute the first defense against many viruses and bacteria that are filtered from the bloodstream. The adaptive immune response originating from the spleen is pivotal in production of IgM-expressing memory B cells and their nonadherent reaction to polysaccharide antigens. Hence anatomic or functional asplenia, together with EDA-ID (caused by NEMO deficiency or IKBKA GOF mutations) and IRAK-4 and MyD88 deficiency, confers the highest risk to invasive infections with pyogenic encapsulated bacteria (S pneumoniae, Haemophilus influenzae, and Neisseria meningitidis).
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RPSA. Isolated congenital asplenia (ICA), the absence of a spleen at birth without associated congenital anomalies, such as cardiopathy as part of heterotaxy syndromes, had been described as a hereditary trait as early as 1968. 124 However, the genetic cause of this inborn error of immunity remained enigmatic until Bolze et al 26 brought together a cohort of 33 patients with ICA presenting with fulminant bacterial infections in early childhood. Hypothesizing genetic homogeneity, they identified heterozygous mutations in ribosomal protein SA (RPSA) as underlying ICA in 18 patients from 8 kindreds. The described mutations resulted in haploinsufficiency of RPSAwith complete penetrance. The cohort of patients has now expanded to include 28 new kindreds. Nine new heterozygous protein-coding mutations are reported. Two mutations located in the 59 untranslated region and 5 protein-coding mutations display incomplete penetrance. 125 RPSA is part of the small subunit of the ribosome, is ubiquitously expressed, and is involved in preribosomal RNA processing. ICA pathogenesis and the role of RPSA in this context are not yet understood. The phenotype associated with RPSA deficiency is striking because haploinsufficiency in 15 other ribosomal proteins has been associated with Diamond-Blackfan anemia and not with splenic anomalies.
DEFECTS IN THE INNATE IMMUNE RESPONSE TO MYCOBACTERIA, SALMONELLA SPECIES, AND CANDIDA SPECIES
Elucidation of the molecular mechanisms underlying MSMD has improved our understanding of the immune response to mycobacteria. All described diseases leading to MSMD affect the IFN-g/IL-12 axis that, through secretion of IFN-g, IL-12, and IL-23 and induction of interferon-stimulated genes (ISGs), forms a loop between APCs and T/NK cells. The IFN-g/IL-12 axis can be impaired by deleterious mutations in genes encoding pathway components, such as type 2 interferon receptor (IFNGR) 1/2, signal transducer and activator of transcription 1 (STAT1), tyrosine kinase 2 (TYK2), and IL-12, but also other proteins, such as cytochrome B-245 b-chain (or gp91phox), which is necessary for oxidative burst in macrophages, and NEMO, which regulates the CD40-dependent production of IL-12 (Fig 1, B) . Some MSMD-causing defects are also responsible for susceptibility to infection with a narrow spectrum of other pathogens, such as Salmonella species, viruses, and Candida species. Indeed, C albicans-induced activation of the NF-kB pathway in phagocytes results in cytokine production, such as IL-12 and IL-23, which leads to activation of T H cells. 126 This results in retinoic acid-related orphan nuclear receptor g T (RORgT)-mediated cellular differentiation and IL-17 release by T H 17 cells, connecting IL-23 function with Candida species immunity (Fig 1, A) . Knowledge on IL-17 immunity up to 2012 has been reviewed by Puel et al. 127 For a comprehensive review of MSMD-causing mutations published before 2013, we refer to Bustamante et al. 128 Inborn errors of IFN-g and IL-12 immunity TYK2. Kreins et al 29 and Kilic et al 28 described a total of 7 new patients from 5 families and 4 ethnicities with mycobacterial (BCG and tuberculosis) and intracellular bacterial (eg, Brucella species) and/or viral infections harboring homozygous mutations in TYK2. None of the patients displayed any of the signs of hyperIgE syndrome (HIES), as reported for the first patient described with AR TYK2 deficiency.
27 TYK2 is expressed in T cells, B cells, NK cells, myeloid cells, and monocytes, and its scaffolding role contributes to the cell-surface expression of type I interferon receptor 1 (IFNAR1), IL-12 receptor b1, and IL-10R2. As expected, the EBV-B cells of the TYK2-deficient patients did not express these receptors on the surface. 29 The responses of both T and NK cells to IL-12 in these patients were impaired but not abolished, accounting for the MSMD. However, TYK2-deficient patients had normal ex vivo percentages of IL-17-producing T cells and did not present a CMC phenotype, despite an impaired response to IL-23 in vitro. Their response to IFN-a/b was completely abolished in Herpesvirus saimiriimmortalized T cells (HSV-T cells) and impaired in EBV-B cells and simian virus 40-immortalized (SV40) fibroblasts, accounting for the viral phenotype. Finally, TYK2-deficient patients' EBV B cells showed very low basal expression of IFN-l-inducible genes, suggesting a role of TYK2 in their regulation.
JAK1. A young man with recurrent nontuberculous mycobacterial infection, warts, onychomycosis, and scabies was found to harbor 2 homozygous missense mutations in Janus kinase 1 (JAK1). 30 The patient succumbed to early-onset bladder carcinoma at 23 years of age. Many cytokines, including IL-2, IL-4, IL-7, IL-9, IL-15, IL-21, IL-27, and the IL-6 and IL-10 family cytokines signal through JAK1. Together with TYK2 and JAK2, JAK1 is a scaffolding protein for type I and II interferon receptors and acts downstream by phosphorylating STAT proteins, such as STAT1 and STAT2. The authors showed impaired phosphorylation of JAK1 and STAT1/2 on stimulation of type I or II interferon receptors and reduced ISG transcription. 30 Also, they showed reduced amounts of phosphorylated TYK2 and JAK2 on stimulation with IFN-a or IFN-g, respectively. Together, these broad signaling defects explain the observed susceptibility to nontuberculous mycobacteria. Interestingly, they demonstrated that JAK1 kinase activity is needed to activate the signaling downstream from type I but not type II interferons because IFN-g stimulation induced STAT1 phosphorylation also in the presence of a loss-of-kinase mutation in JAK1. Occurrence of carcinomas has been described previously in patients treated with JAK1 inhibitors for immunologic disorders, in line with the presentation of this patient. 30, 129 ISG15. Bogunovic et al 31 studied 3 patients from 2 unrelated consanguineous families presenting with MSMD and asymptomatic intracranial calcifications and 3 Chinese siblings with seizures and intracranial calcifications reminiscent of AicardiGouti eres syndrome, the prototypic type I interferonopathy, as reviewed by Rodero et al. 130 All patients harbored homozygous LOF ISG15 mutations. 31, 131 The absence of BCG vaccination in some members of one family homozygous for the mutation accounted for incomplete penetrance of the infectious phenotype. 131 ISG15 is a ubiquitin-like molecule. It is induced by type I interferons, and conversely, it contributes to their downregulation. Primarily expressed by monocytes, myeloid cells, NK cells, and T and B cells, it can covalently bind other proteins in a process called ISGylation. ISG15 also exists in a free form that can act intracellularly or extracellularly, exercising an immunomodulatory function on several immune cells, including neutrophils, NK cells, monocytes, and lymphocytes, and promoting antimicrobial responses, such as by driving IFN-g production. 132 Bogunovic et al 31 demonstrated that granulocytes were the major source of extracellular ISG15 and that NK cells were the key ISG15-responsive leukocytes in terms of IFN-g secretion, accounting for the MSMD phenotype observed in vivo. This neutrophil/NK cell loop can be seen as the innate adjunct to the IL-12/ IFN-g circuit of the adaptive immune system, which is also implicated in patients with MSMD. The authors also showed that intracellular ISG15 deficiency prevented ubiquitin-specific peptidase 18 (USP18) accumulation. USP18 inhibits IFN-a/b signaling, and its decrease is consistent with higher levels of ISG expression in the patient's blood. 133 The observed phenotypic dichotomy of this monogenic disease, with both MSMD and autoinflammation, reflects the different roles of extracellular (secreted) and intracellular ISG15. Unsurprisingly, AR human USP18 deficiency caused by biallelic LOF mutations of USP18 was recently described as a new type I interferonopathy presenting as pseudo-TORCH (toxoplasmosis, other agents, rubella, cytomegalovirus, herpes simplex) syndrome (neonatal neuroinflammation in the absence of typical TORCH infections). 32 Intriguingly, despite the demonstration of a role for ISG15 in antiviral defenses in mice, patients with ISG15 deficiency do not present a phenotype of susceptibility to viral infections.
133
IRF8. Hambleton et al 33 reported an infant presenting with disseminated BCG and CMC requiring HSCT and 2 otherwise healthy subjects with a history of recurrent disseminated but curable BCG disease. All 3 subjects turned out to harbor monoallelic or biallelic mutations in Interferon regulatory transcription factor 8 (IRF8).
33 IRF8 is a transcription factor expressed only in hematopoietic cells. It is a differentiation factor for granulocytes and macrophages and is necessary for development of DCs. AR IRF8 deficiency was associated with the absence of conventional CD11c 1 myeloid DCs, which secrete IL-12, and CD123
1 plasmacytoid dendritic cells (pDCs), the major producers of type I interferons. This DC deficiency was accompanied by monocytopenia with granulocytic hyperplasia and high NK cell counts resembling hemophagocytic lymphohistiocytosis (HLH). 33, 134 T cells were normal in number but displayed impaired IL-17 secretion in response to microbial or mitogen challenge. This finding suggests that T cells nurtured in the absence of an intact DC environment are functionally abnormal. AD IRF8 deficiency is associated with a DC deficiency limited to CD1c 
CD11c
1 cells. 33 These findings demonstrate that the role of IRF8 in the human innate immune system extends beyond involvement in the transcriptional response of myeloid cells to interferons and TLR agonists to the control of DC development.
Intriguingly, the reported patients did not have a phenotype of increased susceptibility to viral infections. Recently, AR IRF8 deficiency has been reported in a family with severe EBV infection and isolated NK cell deficiency of the CD56 dim subset 34 and in a patient with a broad phenotype, including severe recurrent viral infections, DC and monocyte deficiency, and T, B, and NK cell dysfunction. 135 The widespread immunologic manifestations of different IRF8 LOF mutations point to a broader role for this transcription factor than previously thought.
IRF4. Guerin et al 35 recently described a multiplex nonconsanguineous family in which 4 subjects affected by Whipple disease (life-threatening intestinal and systemic infection caused by Tropheryma whipplei) were found to carry a heterozygous LOF mutation in IRF4. There was incomplete penetrance for Whipple disease in the kindred. IRF4 is a lymphocyte-specific transcription factor with pleiotropic effects in T and B cells. In contrast to other IRF proteins, its expression is not regulated by interferons but by pathways responsible for lymphocyte activation. 136 IRF4 is required for the proliferation of CD4 1 T cells in response to mitogens and for the production of IL-2, IL-4, and IFN-g, thus regulating both T H 1 and T H 2 responses. Moreover, it is essential to drive T H 17 responses, partly through activation of RORgT. Finally, it can bind interferon-stimulated response element (ISRE) promoters and either promote or repress the transcription of ISGs while also exercising a negative regulation on TLR signaling. 136, 137 Negishi et al 137 have in fact shown that IRF4 is induced on TLR activation and exercises a negative feedback regulation on TLR signaling, possibly by competing with IRF5 for binding to MyD88. In vivo, IRF4 knockout mice show a more potent inflammatory response and succumb more rapidly than controls on TLR stimulation. 137 In the index family with IRF4 deficiency, the authors demonstrated loss of DNA binding ability to the ISRE promoters and induction of transcription by the mutated IRF4, resulting in impairment of multiple signaling pathways (eg, IFN-g/STAT1, lymphotoxin-a [also known as TNF-b], and IL-2 receptor A). IRF4 haploinsufficiency is another example of how single-gene inborn errors of immunity can underlie lifethreatening infectious disease during primary infection in otherwise healthy subjects.
IL6ST. Schwerd et al 36 studied a child with recurrent, early, severe bacterial respiratory tract and skin infections, bronchiectasis, skeletal anomalies (including craniosynostosis), eczema, and high IgE levels compatible with HIES and found a homozygous LOF mutation in IL-6 signal transducer (IL6ST), which encodes glycoprotein 130 (gp130). gp130 is a ubiquitously expressed cytokine receptor subunit involved in the recognition and signaling of multiple ligands, including IL-6, IL-11, IL-27, and oncostatin M. The authors showed that gp130 deficiency caused a complete loss of IL-6 signaling, as measured by STAT3 phosphorylation in the patient's PBMCs, EBV-B cells, and T lymphoblasts, and impaired responses to IL-27. Recognition of viral nucleic acids by endosomal TLRs, cytosolic RLRs, and DNA sensors. The UNC-93B chaperone protein guides TLR7/8 and TLR9 traffic from the ER to the endosome, where these receptors recognize viral single-stranded RNA and CpG DNA, respectively. These TLRs recruit MyD88, IRAK4, and IRAK1, which activate TRAF3 and TRAF6. TRAF6, in turn, mediates activation of NF-kB, leading to induction of inflammatory cytokine genes, whereas TRAF3 activates IKKa, which catalyzes phosphorylation of IRF7 and induces type I interferon genes (the classic MyD88-dependent pathway). After recognizing the viral dsRNA, UNC-93B2dependent endosomal TLR3 recruits the adapter molecule TRIF for the activation of TBK1 and IKKε, followed by activation of IRF3 and upregulation of interferon production (the alternative TRIF-dependent pathway). IRF8 facilitates activation of NF-kB and IRF7. RLRs, such as MDA5 and RIG-I, recruit mitochondrial MAVS adapter molecules after recognition of cytoplasmic viral dsRNA. Various cytoplasmic dsDNA sensors signal through the ER-located adapter molecule stimulator of interferon genes. Activation of these RNA and DNA signaling pathways results in production of inflammatory cytokines through NF-kB activation and interferon production through TBK1-IKKε-IRF activation. Secreted type I interferons interact with their surface-expressed receptor IFNAR1/2, leading to recruitment and activation of TYK2 and JAK1, which in turn phosphorylate and activate STAT1 and STAT2. The STAT1/STAT2/IRF9 form complexes that interact with ISRE promoters for induction of ISGs expression. Intracellular ISG15 is type I interferon inducible and involved in USP18-dependent regulation of type I interferons and prevention of type I interferon2dependent autoinflammation. Mutations have been described for all proteins shadowed in gray.
T H 17 responses and no susceptibility to fungal infections, both of which are typical in patients with HIES caused by STAT3 LOF. 36, 138 This highlights the essential contribution of the IL-21/STAT3 axis, but not gp130, to T H 17 subset differentiation.
Inborn errors of IL-17 immunity
The key role of the IL-17 pathway in defense against C albicans was demonstrated by discovery of AD IL-17F and AR IL-17 receptor A (IL-17RA), IL-17RC, and NF-kB activator 1 deficiencies underlying ''isolated'' CMC. Interestingly, the phenotype of IL-17RA deficiency was recently reported to be broader than initially thought. 139 Indeed, L evy et al showed that 14 of 21 patients from 12 kindreds had staphylococcal skin disease and that 8 of these 21 patients had recurrent bacterial respiratory tract infections. These data suggest that IL-17RA is essential for mucocutaneous immunity to C albicans in human subjects, and, to a lesser extent, for protection of the skin and mucosae against S aureus. Moreover, Conti et al 140 studied mucosal function of the IL-17 pathway in a mouse model of oropharyngeal candidiasis and found neutrophil recruitment to the tongue of infected mice to be severely impaired in IL-23-and IL-17RA-deficient mice compared with wild-type or IL-12-deficient mice. Therefore despite belonging principally to the adaptive immunity, IL-17 pathway defects also affect the cell-intrinsic immunity of nonhematopoietic tissue, such as fibroblasts, keratinocytes, or epithelial cells.
STAT1. AD STAT1 GOF mutations were first described in 2011. 38 Recent advances in CMC genetics have shown that in more than 50% of CMC cases, a STAT1 GOF mutation can be found, and more than 350 patients with STAT1 GOF mutations have been described to date. 37, 38, 141 The phenotype extends to bacterial, viral, mycobacterial, and invasive fungal infections. 141 Forty percent of patients with STAT1 GOF mutations have autoinflammatory (innate) and autoimmune (adaptive) manifestations, especially hypothyroidism. 141 The stronger interferon signaling found in patients with STAT1 GOF mutations likely underlies these features. Other clinical features include aneurysms and increased risk of carcinoma, and recently, a high prevalence of STAT1 mutations has been described in patients with JC virus-induced progressive multifocal leukoencephalopathy. 142 Immunologically, patients with STAT1 GOF mutations often have low proportions of circulating IL-17-producing T cells. A number of patients have also been found to have low memory B-cell and IgG 2 and/or IgG 4 levels. 141 Based on the knowledge that JAK1 and JAK2 act upstream of STAT1 dimers, the JAK1/2 inhibitors ruxolitinib and, more recently, baricitinib have been successfully introduced into the treatment of patients with STAT1 GOF mutations to reverse autoimmunity and treat CMC. [143] [144] [145] [146] [147] [148] However, major adverse effects, such as infection and a cytokine rebound effect, have been reported in patients treated with ruxolitinib for STAT1 GOF mutations and other conditions. 47, 149, 150 Recently, an international retrospective study on a cohort of 15 patients with STAT1 GOF mutations who received HSCT showed poor overall survival (40%) and poor event-free survival (10%). 151 RORC. Okada et al 39 studied 7 patients from 3 unrelated kindreds presenting with mild CMC and severe mycobacterial infections. All patients had disseminated mycobacterial infection, and 1 died of BCG meningoencephalitis. Deleterious biallelic mutations of retinoic acid receptor-related orphan receptor C (RORC), which encoded RORg and RORgT, were identified as the underlying genetic cause. The disease showed an AR transmission and was fully penetrant. RORgT and RORg are transcription factors, the first restricted to leukocytes and the second expressed ubiquitously. Consistent with the role of RORgT as a master transcription factor for IL-17 production, the patients had abnormally low frequencies of circulating IL-17A-, IL-17F-, and IL-22-producing T cells and group 3 ILCs (ILC3s), accounting for their CMC. 152 On the other hand, impaired antigen-specific IFN-g production by gd and CD4
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1 ab T cells probably accounted for their mycobacterial disease, to which their lack of mucosa-associated invariant T cells and NKT cells could contribute.
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POLA1. XL reticulate pigmentary disorder is a type I interferonopathy characterized by autoinflammation and immunodeficiency. An intronic mutation in DNA polymerase a 1 (POLA1), affecting splicing and reducing the protein expression, was recently found in 21 patients belonging to 12 kindreds. 40 The hemizygous male subjects manifest reticular pigmentation abnormalities with corneal inflammation and hypohydrosis, failure to thrive because of inflammatory bowel disease, characteristic facies, and recurrent severe respiratory infections that are mostly pyogenic but also mycobacterial. 40 An augmented type I interferon response was demonstrated in POLA-1-deficient fibroblasts, with enhanced expression of IRF-and NF-kB-induced genes, such as ISGs, accounting for the autoinflammatory features of the syndrome. Moreover, the authors proved that POLA-1 was involved in generation of cytosolic RNA-DNA, which in turn is a downregulator of the IRF pathway: a deficient POLA-1 polymerase activity in the cytoplasm leads to reduced cytosolic RNA-DNA levels in the patients' cells and enhanced expression of IRF target genes. Finally, the patients showed low plasma levels of IFN-g and IL-17A, which could explain the infectious phenotype. 40 
DEFECTS IN THE INNATE IMMUNE RESPONSE AGAINST VIRUSES
Host antiviral defense is based on recognition of viral nucleic acid intermediates by membrane-bound TLRs or in the cytoplasm by intracellular viral sensors for DNA or RNA, such as RNAsensing retinoic acid-inducible gene I (RIG-I); RLRs, such as melanoma differentiation-associated protein 5 (MDA5); and DNA sensors. Recognition of the microbial ligand by these receptors induces production of antiviral mediators, such as type I and III (IFN-l) interferons, through IRF3 and IRF7 and unique adaptors (Toll/IL-1 receptor domain-containing adaptor molecule 1 [TRIF], mitochondrial antiviral signaling protein [MAVS] , and stimulator of interferon genes).
4,153 Type I and III interferons then activate innate cells, such as NK cells and ILCs, to eliminate virus-infected cells. The importance of the strict regulation of these pathways has been shown by the study of type I interferonopathies, a clinically heterogenic group of hereditary diseases with a constitutive activation of this pathway (Fig 2) . 130 Inborn errors of the TLR3 pathway TLR3 binds double-stranded RNAs (dsRNAs), leading to activation of a signaling cascade in which the adapter molecule TRIF induces polyubiquitination of TNF receptor-associated factor 3 (TRAF3) and activation of IKKε and TANK-binding kinase 1 (TBK1), resulting in IRF3 phosphorylation and induction of a type I interferon response (Fig 2) . 154 Human defects in several components of this pathway (TLR3, TRIF, TRAF3,  TBK1, and UNC93B1) 155-160 have already been described as genetic causes of HSE, often displaying incomplete penetrance. HSE is a rare (1-2 cases/500,000/y) and devastating manifestation of primary HSV-1 infection that mostly affects children between the ages of 6 and 36 months.
161 TLR3 has proved largely redundant for responses to dsRNA in various leukocytes but not in neurons, accounting for the neuron-specific phenotype of TLR3 deficiency. Additionally, TBK1 has been implicated in autophagy, indicating a role in cell-intrinsic immunity of neurons. 162, 163 IRF3. An additional important player in the TLR3 pathway was identified through the genetic study of patients with sporadic HSE. 41, 42 Two patients were found to carry different heterozygous mutations in IRF3, resulting in an impaired type I and III interferon response to HSV-1, as demonstrated in PBMCs and fibroblasts in vitro. 41, 42 Like TRAF3 and TBK1, IRF3 encodes a downstream component of the TLR3 pathway, but deficiencies of any one of these proteins result in a narrow phenotype, primarily affecting the central nervous system-resident cells.
Inborn errors of intracellular viral sensing DBR1. Zhang et al 43 recently described an AR and fully penetrant genetic cause of brainstem viral encephalitis in 5 children from 3 kindreds. Four children presented with brainstem encephalitis from different viruses (HSV-1 and influenza B) between the ages of 10 months and 12 years, and 2 died from the infection. A fifth child manifested brainstem encephalitis from norovirus at age 6 months but had a broader phenotype, including growth and mental retardation, curly hair, and congenital neutropenia. The authors identified biallelic LOF mutations in the gene encoding the only known human RNA lariat debranching enzyme 1 (DBR1), resulting in severely impaired expression and enzymatic activity of DBR1. DBR1 acts by hydrolyzing 29 to 59 branched phosphodiester bonds at the branch point of lariat intron RNA and converting them into linear molecules and ensuring their rapid turnover. It is most represented in the peripheral and central nervous system, especially in the spinal cord and brainstem. 164 In primary fibroblasts from patients, the abundance of intronic lariat RNA was increased accordingly, with a further marked increase after HSV-1 infection. Moreover, the authors showed impaired control of viral infections in patients' fibroblasts, despite intact TLR3-and interferon-responsive pathways. In fact, DBR1 deficiency did not disrupt the TLR3-IFN-a/b and IFN-a/b-STAT1 responses, implying a different and at present still elusive pathogenic mechanism than those underlying HSE of the forebrain.
MDA5. Rare heterozygous GOF mutations of interferoninduced helicase C domain-containing protein 1 (IFIH1) or MDA5 cause AD Aicardi-Gouti eres syndrome, 165, 166 a type I interferonopathy. A child with severe recurrent viral respiratory tract infections caused by human rhinovirus (HRV), influenza virus, and respiratory syncytial virus (RSV) and transiently low levels of immunoglobulins and T, B and NK cell counts was shown to carry a homozygous LOF mutation in MDA5. 44 The authors showed that MDA5 played a nonredundant protective role in the human airways in sensing HRV and initiating innate immune responses against this virus but not other viruses, despite in vivo clinical susceptibility. 44 High levels of HRV replication were observed in MDA5-silenced respiratory epithelial cells or fibroblasts and nasal epithelial cells from the MDA5-deficient patient, and the phenotype was rescued by transduction of fibroblast clones with wild-type MDA5.
Additionally, Asgari et al 45 identified 8 children carrying 3 putative LOF variants (homozygous in 1 patient) of MDA5 in a group of 120 previously healthy children requiring intensive care support for severe illness caused by respiratory viruses (HRV and RSV). These variants were found to have a high allele frequency in the general population (1.9%) and were proved to disrupt MDA5 signaling function, enzyme activity, and protein stability in vitro. Moreover, mutant MDA5 protein interfered with the function and stability of the wild-type protein, suggesting a dominant-negative effect, possibly involving prevention of the formation of normal multimeric MDA5 filaments. The authors suggested that protective effect against type I diabetes and other autoimmune diseases might account for this high frequency. 45 Zaki et al 46 described an additional patient. The broad spectrum of MDA5 mutations again demonstrates the delicate balance between efficient host defense, inflammation and autoimmunity.
POLR3A and POLR3C. Ogunjimi et al 47 have recently identified 4 children from a group of 21 patients affected by acute severe varicella zoster virus (VZV) infection (involving the lung or the central nervous system) harboring mutations in RNA polymerase III (POLR3). Two patients had heterozygous mutations of either POLR3A or POLR3C, and the other 2 patients carried a heterozygous mutation in both genes. The penetrance of the disease is incomplete. The authors demonstrated that induction of interferon type I and III responses by AT-rich DNA in human leukocytes is POL III dependent and that in vitro stimulation of patient-derived leukocytes with synthetic AT-rich DNA (poly [dA:dT]) or VZV genome elicits an impaired interferon response. However, the type I interferon response was normal in patients' PBMCs on stimulation of the RIG-I/MAVS pathway with polyinosinic-polycytidylic acid, which is downstream from POL III. 47 Finally, they showed that patients' PBMCs were not able to restrict VZV virus replication in vitro and that transduction with wild-type POLR3C or POLR3A rescued the control of viral replication in patients' deficient cells.
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SAMD9 and SAMD9L. Very recently, sterile a motif domain-containing protein 9 (SAMD9) was shown to be a host innate antiviral factor against poxvirus (eg, vaccinia and myxoma virus), Japanese encephalitis virus, and low-risk papillomavirus in human subjects. [167] [168] [169] [170] [171] [172] Mutations in SAMD9 and its paralog, sterile a motif domain-containing protein 9-like (SAMD9L), are associated with a heterogeneous clinical phenotype. SAMD9 bears 59% amino acid similarity to SAMD9L. Both are located on 7q21 and are tumor suppressors primarily expressed in hematopoietic cells and induced by TNF-a, IFN-a, and IFN-g. On viral infection, SAMD9 and SAMD9L downregulate interferon-driven hematopoiesis. Recently, 2 groups have identified heterozygous GOF mutations in SAMD9 in children with growth failure, adrenal hypoplasia, genital anomalies, severe enteropathy, thrombocytopenia, and anemia. 48, 173 Most patients succumbed in infancy because of the hematologic manifestations or infection with fungi (Candida species) or bacteria (mostly Staphylococcus species). Thymic size was small. Patients with SAMD9L GOF mutations instead have ataxia-pancytopenia syndrome with variable severity, and some experience viral infections, such as cytomegalovirus (CMV). 49, 174 A subset of J ALLERGY CLIN IMMUNOL VOLUME 143, NUMBER 2 patients had hematopoietic monosomy 7 (by uniparental disomy), deletion of 7q (so-called adaptation by aneuploidy), or neutralization of the GOF mutation by LOF mutations in SAMD9 or SAMD9L. 48, [173] [174] [175] [176] These adaptations were dynamic, progressive, and often multiple and associated with increased survival. However, a subset of patients with monosomy 7 and 7q had MDS, probably because of haploinsufficiency of other 7q21 genes. 49, [174] [175] [176] Inborn errors of type I and III interferon amplification and responses IRF7. In an otherwise healthy child with life-threatening acute respiratory distress syndrome during primary influenza A virus (IAV) infection at the age of 2.5 years, compound heterozygous null mutations of IRF7 were identified. 50 IRF7 is a transcription factor activated downstream of RIG-I, TLR3, TLR7, and TLR9. It plays a crucial role in amplifying interferon type I and III production on detection of virus. 177, 178 It is expressed in abundance by pDCs, the main producers of type I interferons. The authors showed a complete lack of IFN-a2b and decreased IFN-b and IFN-l1 production in the patients' pDCs and PBMCs on exposure to different viruses or TLR stimulation. Moreover, IAV replication was significantly enhanced in the patients' inducible pluripotent stem cell-derived pulmonary epithelial cells and fibroblasts, and this phenotype was rescued by treatment with IFN-a2b, IFN-b, or IFN-l1. The absence of IRF7-dependent type I and III interferon amplification by pDCs, pulmonary epithelial cells, and possibly other cell types probably accounts for the severe phenotype of this patient. By the time at which this case was reported, the child had not experienced other severe infections, implying that human IRF7 is largely redundant in host defense against most common viruses.
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IFNAR2 and STAT2. The key role of type I interferon in host antiviral defense is also highlighted by reports on human AR IFNAR2 and STAT2 deficiencies, displaying a similar phenotype and incomplete penetrance. 51, 52, 179, 180 These patients typically present with complicated vaccine-strain measles after immunization with the live vaccine but can also have life-threatening infections with other viruses. Duncan et al 52 identified a homozygous LOF mutation in IFNAR2 in a previously healthy child who died from encephalitis after administration of live measles vaccine and his newborn sister. The authors demonstrated that the mutation resulted in loss of the IFN-a response in the patient's fibroblasts in vitro. 52 Nine patients with STAT2 deficiency have been described to date: 2 died of viral infections, 6 had severe measles after vaccination, and excessive clinical inflammation has been reported in at least 4 patients (Kawasaki-like syndrome and HLH-like syndrome). 51, 179, 180 The recent finding that STAT2 is essential for USP18-mediated inhibition of type I interferon signaling, at least in the conditions studied in vitro, provides an illustration of the tight regulation embedded in the innate immune system.
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IRF9. Downstream from IFNAR1/2, IRF9 combines with STAT1/STAT2 heterodimers to form the ISGF3 transcription factor. This translocates to the nucleus and initiates transcription after binding to an ISRE promoter. AR IRF9 deficiency was recently characterized in a child who presented with complications after measles-mumps-rubella vaccine, recurrent viral infections, and severe IAV infection requiring intensive care treatment, a clinical picture overlapping with both IRF7 and STAT2 deficiency. 53 The authors demonstrated absent activation of ISGF3 and absent transcription of factors driven by the ISRE promoter, which consequently impairs ISGs expression and antiviral immunity in patients' fibroblasts. The impairment in transcriptional response to interferon stimulation was found to be as broad as that of STAT1-or STAT2-deficient patients.
IFNAR1. Hoyos-Bachiloglu et al 54 have reported a child born from consanguineous parents who at the age of 2 months had Streptococcus viridans sepsis, severe CMV infection, and mycobacteriosis and went on to have HLH. Of note, he later received attenuated measles, mumps, and rubella virus vaccines without any adverse effect. The group identified homozygous mutations in both IFNGR2 and IFNAR1. 54 The mutation in IFNGR2 is LOF and considered responsible for the mycobacterial susceptibility. 54 The mutation in IFNAR1 is a deletion replacing a stop codon with 46 new codons, resulting in a slightly longer protein.
The effect is predicted to be deleterious based on decreased STAT1 and STAT2 phosphorylation, partial impairment of phosphorylated STAT1 nuclear translocation and failure to induce an appropriate antiviral response after IFN-a stimulation of the patient's fibroblasts, which was rescued by transduction with wild-type IFNAR1. 54 However, the simultaneous presence of homozygous mutations in both type I and II interferon pathways renders difficult the attribution of the clinical infectious phenotype to one or the other gene defect.
Inborn errors of NK cells and ILCs
ILCs were recently described as a subfamily of lymphocytes differing from adaptive T cells in their absence of a clonotypic TCR and their independence of gene rearrangement. 182 They are ''innate'' counterparts of differentiated adaptive T cells and are able to respond to threats within hours of activation. ILCs are classified into 3 groups based on their phenotype and functional resemblance to T cytotoxic or helper cells: group 1, group 2, and groups 3 ILCs are driven by T-bet, GATA-3, and RORgt, respectively, and secrete IFN-g, IL-5/IL-13, and IL-17/IL-22, respectively. 183 ILCs are abundant at mucosal surfaces, where they maintain the delicate balance between pathogen containment and avoidance of autoinflammation, particularly in mice. 182, 183 Research into human ILC development and function is in its infancy. V ely et al 184 showed that peripheral blood ILCs other than NK cells were more abundant in umbilical cord blood and in children than in adults. They also showed that patients with T SCID with mutations in IL-2 receptor subunit gamma (IL2RG) or JAK3 had no circulating ILCs, which is consistent with the dependence of these cells on IL-7 and IL-15. Moreover, in the absence of myeloablative conditioning, ILC deficiency persists in blood and tissue after HSCT, with no major detectable clinical effect, even after long-term follow-up, at least in conditions in which functional T and B cells are present, suggesting that ILCs are redundant for host defense in human subjects. The ILC population is reconstituted after myeloablative HSCT, indicating that ILC precursors are present in human bone marrow and cord blood. 184 Long-term observations in a larger number of patients are required to assess the potential increase in cancer risk and to determine whether the observed redundancy persists with aging. However, recent studies have shown that NK cells, group 1 ILCs, group 2 ILCs, and IL-22
1 ILC3s but not IL-17A 1 ILC3s can develop from ILC precursors in RORC-deficient patients. 152 Therefore it is possible that the lack of ILC3s in human subjects with biallelic LOF RORC mutations contributes to the susceptibility of these subjects to infection with Candida species and mycobacteria.
The role of NK cells in human immune defense remains a matter of debate and is accurately reviewed in several newly published papers. 34, 185, 186 The patient described by Biron et al 187 in 1989 with severe varicella, recurrent viral infections, NK cell deficiency, and lack of NK cytotoxic function was later found to harbor a mutation in GATA-2. Mace et al 188 went on to characterize the NK cell defect of GATA-22deficient patients (see paragraph on GATA-2). In another child with fatal varicella infection and NK cell deficiency with abolished NK cytotoxic function, Hanna et al 189 found a homozygous mutation in RTEL1, which is responsible for a form of dyskeratosis congenita with bone marrow failure (Hoyeraal-Hreidarsson syndrome). These reports highlight how NK cells can be first affected in a variety of inborn errors, preceding the development of defects in other hematopoietic cell lines and therefore deserve to be accurately studied. Novel findings in NK defects include the discovery of defects in minichromosome maintenance (MCM) 4, Go-Ichi-Ni-San complex subunit 1 gene (GINS1), IRF8, and the extended phenotype of GATA-2 deficiency.
MCM4. Two independent groups recently identified a homozygous mutation in MCM4 in 14 patients from 5 kindreds with NK cell deficiency, severe viral infection (EBV, CMV, and other viruses), growth failure, and adrenal failure. 55, 56 These patients displayed a selective loss of mature CD56 dim NK cells caused by blocking of the differentiation of CD56 bright into CD56 dim cells, lack of proliferation, and excess of spontaneous apoptosis of both CD56 bright and CD56 dim NK cells. Moreover, the patients showed signs of increased DNA breakage, highlighting the essential role of MCM4 in DNA replication during cell division.
GINS1. NK cell deficiency associated with neutropenia and intrauterine growth retardation has been reported in 5 patients from 4 kindreds displaying enhanced susceptibility to viral (CMV, VZV, RSV, and adenovirus), bacterial, and fungal infections. All the affected patients had compound heterozygous mutations of GINS1. 58 The GINS complex, like the MCM2-7 complex containing MCM4, is part of the CMG helicase (Cdc45, Mcm2-7, and GINS), which is essential for eukaryotic DNA replication. Unlike patients lacking MCM4, patients with GINS1 deficiency have abnormally low numbers of both CD56 bright and CD56 dim NK cells. Finally, these patients have an excess of promyelocytes with reduced metamyelocyte and mature neutrophil levels, which can be corrected by using G-CSF treatment.
GATA2. Heterozygous mutations in GATA2, resulting in haploinsufficiency of GATA-2, are responsible for AD monocytopenia and Mycobacterium avium complex/dendritic cell, monocyte, B, and NK lymphocyte deficiency (MonoMAC) syndrome; Emberger syndrome; and familial MDS/acute myeloid leukemia. [59] [60] [61] [62] The immunophenotype is characterized by monocytopenia and B-cell and NK cell lymphopenia, clinically translating into mycobacterial, fungal, and viral infections. The clinical spectrum has been extended in the last 5 years and involves susceptibility to disseminated nontuberculous mycobacterial infections, papillomavirus infections, opportunistic fungal infections, and pulmonary alveolar proteinosis; lymphedema, hearing loss, and risk of miscarriage are also reported. 190 In 2013, Mace et al 188 showed that the CD56 bright NK cells of GATA-22deficient patients are absent or severely reduced in numbers and that CD56 dim cells are functionally impaired. Other characteristics are B-cell, monocyte, and DC deficiency; bone marrow hypocellularity; and myeloid dysplasia, often with karyotypic abnormalities leading to MDS and leukemia. 59, 190, 191 The only available treatment is HSCT, but the timing of this intervention is a matter of debate. 192 
FUTURE DIRECTIONS AND CONCLUSION
We have reviewed here a set of recently described inborn errors of innate immunity conferring susceptibility to infection. The studies we described offer insights into the close interplay between innate and adaptive immunity and the redundancy of some innate immune pathways and factors that can be traced back to the evolution of adaptive immunity. The innate immune system is more conserved through the species than the adaptive immune system; nonetheless, a great degree of variation has characterized the development of human innate immunity.
Patin et al 193 have recently used flow cytometry and a genomewide association approach to study 1000 healthy subjects and have found that natural variation in the parameters of innate cells, such as cell-surface expression of protein markers, is more strongly driven by genetic factors than in adaptive cells. In most of the inborn errors of innate immunity discussed here, adaptive immunity is also affected to some extent and, conversely, defects manifesting as T-and B-cell dysfunction often display some innate immunity involvement, as is the case in defects of NF-kB and the CBM complex. Some defects, such as those in the TLR3 pathway or in the type I/III interferon pathway, show redundancy of the pathway for host defense in general: the phenotype is in fact restricted to impaired cell-intrinsic immunity against 1 or a limited number of pathogens and in a single nonhematopoietic cell line. TIRAP deficiency, which causes only an infectious susceptibility in the absence of anti-LTA antibodies, is a fine example of both the redundancy of an innate pathway and the mutual influence of innate and adaptive immunity.
Finally, we show that tight regulation of the immune pathways is crucial to confer protection from infections while avoiding autoinflammation. In many conditions discussed here, the increased susceptibility to infection is associated with autoinflammation, and defects in the same gene can cause either immunodeficiency or autoinflammation, depending on their detrimental or enhancing effect on protein function, such as in STAT1 and MDA5 mutations. Infection and autoinflammation can be allelic.
From a clinical perspective, the inborn errors of innate immunity also teach us that the absence of a measurable immunologic defect (eg, hypogammaglobulinemia) does not exclude an immunodeficiency and should not result in a delay in treatment. Moreover, many of the described clinical entities present with hematologic manifestations that can dominate the phenotype and result in fatal outcome (eg, MDS/acute myeloid leukemia in GATA-2 deficiency and SAMD9 GOF mutation). The intertwinement of these manifestations also shows the importance of regulation of hematopoiesis on infection. The genetic theory of infectious diseases 13 suggests that many inborn errors of immunity in general and of innate immunity in particular are yet to be characterized by the study of patients with severe infections. Explaining the underlying mechanisms of increased resistance to disease after infection with a pathogenic microbe is another J ALLERGY CLIN IMMUNOL VOLUME 143, NUMBER 2 challenge. Ultimately, these experiments of nature will improve our knowledge and understanding of human (innate) immunity to infection and should enable us to provide better treatment to individual patients and entire populations.
